Brain Slices from Glutaminase-Deficient Mice Metabolize Less Glutamine: A Cellular Metabolomic Study with Carbon 13 NMR
- 29 February 2012
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 32 (5) , 816-824
Abstract
In the brain, glutaminase is considered to have a key role in the provision of glutamate, a major excitatory neurotransmitter. Brain slices obtained from wild-type (control) and glutaminase-deficient (GLS1 +/–) mice were incubated without glucose and with 5 or 1 mmol/L [3-13C]glutamine as substrate. At the end of the incubation, substrate removal and product formation were measured by both enzymatic and carbon 13 nuclear magnetic resonance (13C-NMR) techniques. Slices from GLS1 +/– mice consumed less [3-13C]glutamine and accumulated less [3-13C]glutamate. They also produced less 13CO2 but accumulated amounts of 13C-aspartate and 13C-gamma-aminobutyric acid (GABA) that were similar to those found with brain slices from control mice. The newly formed glutamine observed in slices from control mice remained unchanged in slices from GLS1 +/– mice. As expected, flux through glutaminase in slices from GLS1 +/– mice was found diminished. Fluxes through all enzymes of the tricarboxylic acid cycle were also reduced in brain slices from GLS1 +/– mice except through malate dehydrogenase with 5 mmol/L [3-13C]glutamine. The latter diminutions are consistent with the decreases in the production of 13CO2 also observed in the slices from these mice. It is concluded that the genetic approach used in this study confirms the key role of glutaminase for the provision of glutamate.Keywords
This publication has 32 references indexed in Scilit:
- Rat brain slices oxidize glucose at high rates: A 13C NMR studyNeurochemistry International, 2011
- Relationship Between Genetic Variation in the Glutaminase Gene GLS1 and Brain Glutamine/Glutamate Ratio Measured In VivoBiological Psychiatry, 2011
- Glutaminase-Deficient Mice Display Hippocampal Hypoactivity, Insensitivity to Pro-Psychotic Drugs and Potentiated Latent Inhibition: Relevance to SchizophreniaNeuropsychopharmacology, 2009
- Mice Lacking Brain/Kidney Phosphate-Activated Glutaminase Have Impaired Glutamatergic Synaptic Transmission, Altered Breathing, Disorganized Goal-Directed Behavior and Die Shortly after BirthJournal of Neuroscience, 2006
- Characteristics of glutamine metabolism in human precision-cut kidney slices: a 13C-NMR studyBiochemical Journal, 2005
- Kinetics and localization of brain phosphate activated glutaminaseJournal of Neuroscience Research, 2001
- Alanine Metabolism in Isolated Human Kidney TubulesEuropean Journal of Biochemistry, 1996
- The orientation of phosphate activated glutaminase in the inner mitochondrial membrane of synaptic and non-synaptic rat brain mitochondriaNeurochemistry International, 1995
- Glutamate immunoreactivity in rat cerebral cortex is reversibly abolished by 6-diazo-5-oxo-L-norleucine (DON), an inhibitor of phosphate-activated glutaminase.Journal of Histochemistry & Cytochemistry, 1994
- Carbon-13-NMR of peptides and proteinsProgress in Nuclear Magnetic Resonance Spectroscopy, 1978